Camber Capital Management’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-262,900
Closed -$2.32M 47
2022
Q1
$2.32M Buy
+262,900
New +$1.99M 0.08% 37
2021
Q4
Sell
-1,500,000
Closed -$18.6M 45
2021
Q3
$18.6M Hold
1,500,000
0.57% 36
2021
Q2
$27.4M Hold
1,500,000
0.92% 32
2021
Q1
$31.3M Sell
1,500,000
-575,000
-28% -$12.1M 1.07% 27
2020
Q4
$37.1M Hold
2,075,000
1.3% 26
2020
Q3
$23.5M Buy
2,075,000
+1,700,000
+453% +$21M 1.24% 25
2020
Q2
$5.11M Buy
+375,000
New +$5.16M 0.29% 29
2018
Q1
Sell
-1,000,000
Closed -$31.8M 41
2017
Q4
$31.8M Sell
1,000,000
-150,000
-13% -$4.71M 1.56% 21
2017
Q3
$44.3M Buy
1,150,000
+1,050,000
+1,050% +$41.2M 2.81% 16
2017
Q2
$4.52M Buy
+100,000
New +$3.82M 0.22% 34

Other funds holding RDUS

Camber Capital Management's RDUS Position: Q2 2022 in Review

Camber Capital Management sold out of Radius Health, Inc. (RDUS) in Q2 2022, closing a stake of 262,900 shares — an estimated $2.32M sold.

Camber Capital Management first reported a position in RDUS in Q2 2017 and held it in 10 quarters. The position peaked at $44.3M in Q3 2017. 123 funds tracked by Wall St. Rank hold RDUS as of Q2 2022.

  • Camber Capital Management reported no remaining Radius Health, Inc. position as of Q2 2022 after selling out during the quarter.
  • Camber Capital Management sold 262,900 Radius Health, Inc. shares in Q2 2022, an estimated $2.32M.
  • Camber Capital Management first reported a position in Radius Health, Inc. in Q2 2017 and held it in 10 quarters.
  • Camber Capital Management's Radius Health, Inc. position peaked at $44.3M in Q3 2017.
  • 123 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q2 2022.

Based on Camber Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.